熱門資訊> 正文
Virax Biolabs extends distribution agreement to market Mpox detection kits
2024-09-16 20:37
- Virax Biolabs (NASDAQ:VRAX) said it has entered into an extension of its already existing exclusive distribution agreement with Cosmos Health (COSM) to commercialize Mpox Virus Real-Time PCR Detection kits.
- The agreement is for the commercialization of the kits in countries in the Gulf Cooperation Council.
More on Virax Biolabs Group Limited
- Mpox Stocks Have Popped, But Pickings Are Slim For The Discerning Investor
- Singapore announces quarantine measures for close contacts of mpox infected patients
- Virax stock rallies 22% on mpox detection kit deal
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
